McIlrath & Eck’s Dorman Products DORM Stock Holding History

McIlrath & Eck’s Portfolio DORM Stock Details DORM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-183	Closed	-$22.5K	–	1649
2025 Q4	$22.5K	Sell	183 -103	-36%	-$13.9K	﹤0.01%	490
2025 Q3	$44.6K	Buy	286 +103	+56%	+$14.8K	﹤0.01%	345
2025 Q2	$22.4K	Buy	+183	New	+$22.3K	﹤0.01%	459

Other funds holding DORM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

McIlrath & Eck's DORM Position: Q1 2026 in Review

McIlrath & Eck sold out of Dorman Products (DORM) in Q1 2026, closing a stake of 183 shares — an estimated $22.5K sold.

McIlrath & Eck first reported a position in DORM in Q2 2025 and held it in 3 quarters. The position peaked at $44.6K in Q3 2025. 318 funds tracked by Wall St. Rank hold DORM as of Q1 2026.

McIlrath & Eck reported no remaining Dorman Products position as of Q1 2026 after selling out during the quarter.
McIlrath & Eck sold 183 Dorman Products shares in Q1 2026, an estimated $22.5K.
McIlrath & Eck first reported a position in Dorman Products in Q2 2025 and held it in 3 quarters.
McIlrath & Eck's Dorman Products position peaked at $44.6K in Q3 2025.
318 funds tracked by Wall St. Rank held Dorman Products as of Q1 2026.

Based on McIlrath & Eck's 13F filing for Q1 2026, filed 19 May 2026.